Interferon-stimulated genes and their antiviral effector functions

By John W. Schoggins, Charles M. Rice. Current Opinion in Virology, 2011

1,282 citations recorded by the source corpus.

Many viruses trigger the type I interferon (IFN) system, leading to the transcription of hundreds of interferon-stimulated genes (ISGs). The products of these ISGs exert numerous antiviral effector functions, many of which are still not fully described. Recent efforts have been aimed at identifying which ISGs are antiviral and further characterizing their mechanisms of action. IFN effectors vary widely in their magnitude of inhibitory activity and display combinatorial antiviral properties. Collectively, ISGs can target almost any step in a virus life cycle. Some of the most potent antiviral effectors reinforce the system by further inducing IFN or ISGs. Other genes enhance or facilitate viral replication, suggesting that some viruses may have evolved to co-opt IFN effectors for a survival advantage.

Subfields: Immunology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/586316e4ba8fae180a835b3898cbcb2b9d7c7c60

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. Anna Marie Pyle
  2. Megan E. Fitzgerald
  3. A. Iwasaki
  4. T. Dickey
  5. Wenshuai Wang
  6. Michael S. Diamond
  7. O. Potapova
  8. A. García‐Sastre

In Molecular Biology

  1. Anna Marie Pyle
  2. Manolis Kellis
  3. Megan E. Fitzgerald
  4. Paul Flicek
  5. Daniel R. Zerbino
  6. T. Dickey
  7. Benedict Paten
  8. Fiona Cunningham

In Oncology

  1. Anna Marie Pyle
  2. Michael S. Diamond
  3. A. Iwasaki
  4. Zemin Zhang
  5. Herbert W. Virgin
  6. Wenshuai Wang

Citations in the corpus